William E Gooding Selected Research

William E Gooding Research Topics

Disease

65	Neoplasms (Cancer) 06/2020 - 03/2002
42	Squamous Cell Carcinoma of Head and Neck 01/2022 - 03/2002
15	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 09/2004
7	Neoplasm Metastasis (Metastasis) 01/2016 - 03/2002
7	Melanoma (Melanoma, Malignant) 11/2012 - 09/2007
6	Lung Neoplasms (Lung Cancer) 12/2015 - 03/2002
5	Carcinogenesis 01/2018 - 09/2004
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2017 - 03/2005
5	Adenocarcinoma 02/2013 - 01/2006
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 11/2009
4	Sarcoma (Soft Tissue Sarcoma) 10/2016 - 10/2003
4	Lymphatic Metastasis 01/2016 - 04/2006
3	Esophageal Neoplasms (Esophageal Cancer) 05/2011 - 03/2002
3	Pneumothorax 03/2009 - 05/2007
2	Carcinoma (Carcinomatosis) 10/2016 - 11/2013
2	Fatigue 01/2012 - 06/2005
2	Gastroesophageal Reflux (GERD) 09/2011 - 01/2005
2	Necrosis 04/2003 - 12/2002
1	Dermatitis 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Bites and Stings (Sting) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2017
1	Pleomorphic Adenoma 10/2016
1	Mouth Neoplasms (Oral Cancer) 08/2016

Drug/Important Bio-Agent (IBA)

22	ErbB Receptors (EGF Receptor)IBA 10/2018 - 08/2002
13	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2002
10	Cetuximab (Erbitux)FDA Link 01/2022 - 09/2006
9	Biomarkers (Surrogate Marker)IBA 06/2020 - 11/2012
6	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 01/2005
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2017 - 12/2006
5	Messenger RNA (mRNA)IBA 01/2018 - 03/2002
5	src-Family KinasesIBA 01/2017 - 08/2003
5	LigandsIBA 12/2006 - 03/2002
4	Monoclonal AntibodiesIBA 06/2020 - 03/2002
4	OligonucleotidesIBA 02/2013 - 03/2008
4	Transcription Factors (Transcription Factor)IBA 08/2012 - 10/2004
4	Bombesin Receptors (Bombesin Receptor)IBA 03/2008 - 03/2002
4	Antisense OligonucleotidesIBA 03/2008 - 09/2003
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2020 - 07/2011
3	Antisense DNAIBA 10/2018 - 05/2002
3	CytokinesIBA 01/2018 - 12/2002
3	Tyrosine (L-Tyrosine)FDA Link 08/2016 - 03/2008
3	Sulindac (Copal)FDA LinkGeneric 06/2014 - 12/2006
3	Biological ProductsIBA 04/2014 - 09/2006
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2012 - 03/2008
3	Transforming Growth Factor alpha (TGF-alpha)IBA 03/2008 - 09/2004
2	IpilimumabIBA 01/2022 - 01/2019
2	InterferonsIBA 01/2018 - 11/2012
2	Nucleic AcidsIBA 01/2018 - 01/2005
2	Dasatinib (BMS 354825)FDA Link 01/2017 - 01/2016
2	Phosphotransferases (Kinase)IBA 10/2016 - 07/2008
2	Antineoplastic Agents (Antineoplastics)IBA 04/2014 - 12/2002
2	Carboplatin (JM8)FDA LinkGeneric 10/2013 - 12/2002
2	tremelimumabIBA 11/2012 - 01/2012
2	Peptides (Polypeptides)IBA 11/2012 - 10/2003
2	Tyrosine Kinase InhibitorsIBA 11/2012 - 12/2006
2	Epidermal Growth Factor (EGF)IBA 11/2012 - 09/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2012 - 05/2012
2	AntigensIBA 05/2012 - 03/2005
2	Gefitinib (Iressa)FDA Link 07/2011 - 07/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2011 - 02/2005
2	Interleukin-2 (IL2)IBA 10/2008 - 09/2007
2	Docetaxel (Taxotere)FDA Link 03/2008 - 10/2003
2	Cisplatin (Platino)FDA LinkGeneric 09/2006 - 10/2004
2	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2006 - 11/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2005 - 08/2002
2	Cyclin D1IBA 02/2005 - 08/2002
1	SteroidsIBA 01/2022
1	ficlatuzumabIBA 06/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	rilotumumabIBA 08/2017
1	TOR Serine-Threonine KinasesIBA 12/2016
1	Everolimus FDA Link 12/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2016
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 10/2016
1	Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)IBA 10/2016
1	CarcinogensIBA 08/2016
1	statticIBA 08/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2016
1	Discoidin Domain Receptor 2IBA 01/2016
1	NucleotidesIBA 01/2016
1	Caspase 8 (Caspase-8)IBA 01/2016
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2016

Therapy/Procedure

17	Therapeutics 01/2019 - 09/2002
8	Radiotherapy 01/2022 - 01/2003
5	Immunotherapy 11/2017 - 10/2008
4	Radiofrequency Ablation 11/2009 - 04/2003
4	Catheters 03/2009 - 04/2003
3	Drug Therapy (Chemotherapy) 10/2008 - 06/2005
2	Injections 10/2018 - 11/2004
2	Free Tissue Flaps 01/2017 - 12/2014
2	Aftercare (After-Treatment) 01/2017 - 12/2015
2	Chemoprevention 08/2016 - 02/2011
2	Length of Stay 12/2014 - 03/2011
2	Esophagectomy 02/2013 - 04/2009
2	Neoadjuvant Therapy 11/2012 - 05/2011
2	Neck Dissection (Radical Neck Dissection) 02/2011 - 11/2009
2	Brachytherapy 11/2009 - 09/2006
1	Organ Transplantation 09/2017
1	Precision Medicine 01/2016